Analysts’ Opinions Are Mixed on These Real Estate Stocks: Camden Property (CPT), Omega Healthcare (OHI) and Weyerhaeuser (WY)
Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Camden Property (CPT), Omega Healthcare (OHI) and Weyerhaeuser (WY).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Camden Property (CPT)
In a report released today, Brad Heffern from RBC Capital maintained a Hold rating on Camden Property, with a price target of $105.00. The company’s shares closed last Friday at $104.45.
According to TipRanks.com, Heffern is a 5-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Camden Property with a $111.77 average price target, representing a 5.4% upside. In a report issued on May 2, TipRanks – OpenAI also downgraded the stock to Hold with a $113.00 price target.
See today’s best-performing stocks on TipRanks >>
Omega Healthcare (OHI)
RBC Capital analyst Michael Carroll maintained a Hold rating on Omega Healthcare on May 1 and set a price target of $48.00. The company’s shares closed last Friday at $46.98.
According to TipRanks.com, Carroll is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Omega Healthcare with a $49.78 average price target, implying a 5.9% upside from current levels. In a report issued on April 29, BMO Capital also maintained a Hold rating on the stock with a $50.00 price target.
Weyerhaeuser (WY)
RBC Capital analyst Matt McKellar maintained a Buy rating on Weyerhaeuser on May 1 and set a price target of $30.00. The company’s shares closed last Friday at $23.99.
According to TipRanks.com, McKellar is a 3-star analyst with an average return of
Currently, the analyst consensus on Weyerhaeuser is a Moderate Buy with an average price target of $32.00, implying a 28.1% upside from current levels. In a report issued on April 20, BMO Capital also maintained a Buy rating on the stock with a $38.00 price target.
Read More on CPT:
